Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.49%46.85K | 1.52%-9.6K | 154.97%9.51K | 99.12%-37.32K | 83.94%-59.85K | 305.54%49.57K | 98.81%-9.75K | 99.42%-17.3K | 47.25%-4.22M | 64.39%-372.69K |
| Net income from continuing operations | 103.71%73.79K | 99.52%-12.95K | 70.58%-298.86K | 84.95%-3.15M | 137.21%2.52M | -68.05%-1.99M | -6.10%-2.67M | 90.29%-1.02M | -33.04%-20.95M | -48.97%-6.78M |
| Operating gains losses | 936.05%3.9K | 11.89%-6.39K | 82.13%-1.49K | -107.81%-689.69K | -107.63%-673.61K | -100.85%-466 | -304.71%-7.26K | 84.28%-8.36K | 1,016.94%8.83M | 813.66%8.83M |
| Depreciation and amortization | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -92.34%9.88K | -99.99%1 |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --1.29M | ---1 |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---5.14M |
| Other non cashItems | -122.96%-88.53K | -201.30%-372.14K | -3.94%336.65K | 10.68%1.44M | -46.65%338.43K | 98.99%385.66K | 53.31%367.37K | 49.19%350.47K | 6.70%1.3M | 178.52%634.39K |
| Change In working capital | -96.51%57.7K | -83.41%381.88K | -104.08%-26.79K | -55.40%2.36M | -207.83%-2.25M | 81.80%1.65M | 58.53%2.3M | -22.88%656.28K | -33.16%5.3M | -58.86%2.09M |
| -Change in receivables | -128.19%-7.55K | -107.00%-2.02K | 369.04%49.29K | -7.11%192.61K | 386.75%155.29K | 25.46%26.78K | -87.51%28.86K | -303.45%-18.32K | 215.23%207.35K | 63.79%-54.16K |
| -Change in prepaid assets | --0 | ---- | ---- | -98.97%19.28K | --0 | --0 | -95.58%19.28K | --0 | -44.76%1.88M | -64.89%566.14K |
| -Change in payables and accrued expense | -95.99%65.25K | -82.97%383.9K | -111.28%-76.08K | -33.00%2.15M | -252.79%-2.4M | 165.60%1.63M | 187.07%2.25M | 181.67%674.6K | -31.74%3.21M | -56.37%1.57M |
| Cash from discontinued investing activities | 0 | |||||||||
| Operating cash flow | -5.49%46.85K | 1.52%-9.6K | 154.97%9.51K | 99.12%-37.32K | 83.94%-59.85K | 305.54%49.57K | 98.81%-9.75K | 99.42%-17.3K | 49.96%-4.22M | 70.17%-372.69K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 1,498.97%525.2K | 100.00%1 | |||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --525.2K | --1 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 1,498.97%525.2K | 100.00%1 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 0 | -46.74%3.72M | -67.50%393K | |||
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 50.39%110K | ---- |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -47.76%3.61M | -64.12%283K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -46.74%3.72M | -66.51%393K |
| Net cash flow | ||||||||||
| Beginning cash position | -97.79%234 | -51.69%9.83K | -99.14%325 | 241.31%37.65K | 247.04%60.17K | -73.79%10.61K | 97.76%20.35K | 241.31%37.65K | -99.26%11.03K | -80.50%17.34K |
| Current changes in cash | -5.49%46.85K | 1.52%-9.6K | 154.97%9.51K | -240.22%-37.32K | -394.72%-59.85K | 314.43%49.57K | -132.31%-9.75K | -2,240.32%-17.3K | 101.79%26.62K | 126.07%20.31K |
| Effect of exchange rate changes | ---- | --0 | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| End cash Position | -21.76%47.08K | -97.79%234 | -51.69%9.83K | -99.14%325 | -99.14%325 | 247.04%60.17K | -73.79%10.61K | 97.76%20.35K | 241.31%37.65K | 241.31%37.65K |
| Free cash from | -5.49%46.85K | 1.52%-9.6K | 154.97%9.51K | 99.12%-37.32K | 83.94%-59.85K | 305.54%49.57K | 98.81%-9.75K | 99.42%-17.3K | 50.17%-4.22M | 70.99%-372.69K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.